New EU Approach On Duplicate Marketing Authorizations Prompts Questions
The European Commission says there is no automatic link between the introduction of a duplicate marketing authorization by the holder of the original medicinal product (be it a chemical or a biological medicinal product) and the increased availability of said medicine.